Breast Cancer Screening: A Study on Its Effectiveness
Background on Breast Cancer Screening in Ontario
A recent study aimed to provide evidence regarding the effectiveness of breast cancer screening by examining the stage and type of cancer. In Ontario, Canada, women aged 50 and above are recommended to participate in routine breast cancer screenings. However, in recent years, some researchers have raised concerns about the effectiveness of these screenings.
Concerns Raised by Researchers
Critics of breast cancer screening present two primary arguments. First, they highlight that approximately one-third of women diagnosed through screening may receive false-positive results. Second, there is the concern that screening has not led to a decrease in late-stage breast cancer diagnoses.
The Role of Mammograms in Screening
Breast cancer screening typically involves mammograms, which are X-ray examinations of breast tissue. The objective of a mammogram is to detect breast cancer at an earlier stage than would be possible through self-examination or physician diagnosis. Early detection is believed to enhance the chances of successful treatment.
Assessing the Effectiveness of Breast Cancer Screening
Research Objectives
A research group based in Ontario aimed to evaluate the actual effectiveness of breast cancer screening in identifying early-stage cancer. They sought to understand why some cancers continue to be diagnosed at later stages in women who participate in screening. The findings of their study were published in the Journal of Cancer Research and Clinical Oncology.
Methodology of the Study
The research compared the stage of breast cancer at the time of screening with the stage when a lump became noticeable. The type of breast cancer detected through screening versus that identified by physical examination was also analyzed, as the aggressiveness of the cancer plays a crucial role in treatment outcomes.
Study Results
The study analyzed data from 2,882 women diagnosed with breast cancer over four years, all of whom had undergone a mammogram with the Ontario Breast Screening Program within 28 months prior to their diagnosis. Of these women, 1,091 had cancers that were not detected during the initial mammogram.
Findings on Cancer Detection
The researchers found that the cancers missed by mammograms tended to be more aggressive. They theorized that these tumors likely developed rapidly after the routine screening. This observation may explain why the standard two-year interval for breast cancer screenings has not significantly reduced the incidence of late-stage diagnoses. Conversely, cancers identified through screening were found to be three times more likely to be in the early stage, irrespective of their aggressiveness.
Conclusion: The Value of Breast Cancer Screening
The study concluded that breast cancer screening continues to hold value. However, it suggested that fast-growing aggressive cancers may require revised screening strategies, focusing on identifying patients at a higher risk for these types of cancers.
References
Holloway C, Jiang L, Whitehead M, Racz J, Groome P. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype. J Cancer Res Clin. 2018:1–7. doi:10.1007/s00432-018-2687-4.